Peptency Academy · Compound
Epitalon (epithalon, Ala-Glu-Asp-Gly)
PubChem title: Epitalon. Catalog chemistry record: name Epitalon, also known as Epithalon, sequence Ala-Glu-Asp-Gly, length 4.1 PubChem CID 2190422 Peptency catalog chemistry record, Epitalon A 2025 review in the International Journal of Molecular Sciences, titled as an overview of epitalon as a pineal tetrapeptide, covers in vitro, in vivo and in silico studies of epitalon. Source sentence
PubMed title: "Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties." Measured: overview of in vitro, in vivo and in silico studies of epitalon.3 Int J Mol Sci 2025 PubChem records epitalon under CID 219042: formula C14H22N4O9, about 390.35 Da, CAS 307297-39-8. Source sentence
Title: Epitalon; MolecularFormula: C14H22N4O9; MolecularWeight: 390.35; CAS: 307297-39-81 PubChem CID 219042
Research at a glance
Of the 3 primary studies on Epitalon reviewed here, all are lab or animal studies; none is in humans.
- Most human model studied
- Animal studies
- Studies reviewed
- 3: 2 lab, 1 animal
- Registered trials
- 0
- EMA
- No authorisation found
- WADA
- Not named
Regulatory content shown for: EU and UK.
Tetrapeptide, 4 residues
- Catalog recordEpitalon4 residuesabout 390.35 DaSource sentence
Title: Epitalon; MolecularFormula: C14H22N4O9; MolecularWeight: 390.35; CAS: 307297-39-8
1 PubChem CID 219042
Known, not known, contested
Known
- The formula computed from the catalog sequence, C14H22N4O9, matches the formula PubChem records, and PubChem confirms the CAS number 307297-39-8 for CID 219042. Source sentence
Catalog chemistry record cross check (5 Oct 2026): formulaFromSequence C14H22N4O9; PubChem formula C14H22N4O9; casConfirmedByPubChem true.
1 PubChem CID 2190422 Peptency catalog chemistry record, Epitalon - A 2003 lifelong study in female mice measured biomarkers of ageing, lifespan and spontaneous tumour incidence after epitalon. Source sentence
PubMed title: "Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice." Measured: lifelong study in female mice of epitalon on biomarkers of ageing, lifespan and spontaneous tumour incidence.
4 Biogerontology 2003 - A 2004 study in human fetal fibroblasts examined cell division and telomerase after exposure to epithalon. Source sentence
PubMed title: "Peptide promotes overcoming of the division limit in human somatic cell." Measured: studied proliferative potential and telomerase in human fetal fibroblasts exposed to epithalon.
5 Bull Exp Biol Med 2004 - A 2025 study measured telomere length and telomerase activity in human cell lines exposed to epitalon. Source sentence
PubMed title: "Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity." Measured: telomere length and telomerase activity in human cell lines exposed to epitalon.
6 Biogerontology 2025
Not known
- ClinicalTrials.gov listed no registered study for epitalon or epithalon on 5 Oct 2026. Source sentence
query.intr epitalon or epithalon: registered 0.
7 ClinicalTrials.gov search for Epitalon, 5 October 2026 - Neither Drugs@FDA nor the EMA medicines data listed an epitalon or epithalon medicine on 5 Oct 2026. Source sentence
openFDA Drugs@FDA lookup of the names epitalon, epithalon: 0 applications. EMA medicines data lookup of the name epitalon: 0 procedures.
8 openFDA Drugs@FDA query for epitalon and epithalon, 5 October 20269 EMA medicines data, 5 October 2026 - Of the 140 PubMed records matching epitalon on 5 Oct 2026, this page reads 4. The other records are not summarised here. Source sentence
PubMed record count for the query: 140; records read for this page: 4 (mouse lifespan study, cell culture studies, one review).
10 PubMed search for Epitalon, 5 October 2026
Contested
Nothing listed yet.
Chemistry: Epitalon as PubChem CID 219042 records it
- Sequence
AEDG- Length
- 4 residues
- Formula
- C14H22N4O9
- Average mass
- 390.35 Da
- CAS
- 307297-39-8
- PubChem CID
- 219042
- Synonyms
- Epithalon, Epitalon
- Salt form
- No salt form stated in the record
Sequence
AEDG
Published literature
- On 5 Oct 2026 PubMed held 140 records matching Epitalon by title and abstract, of which 1 carry the clinical trial publication type and 14 the review type. This page reads 4 of them. Source sentence
PubMed record count for the query (epitalon[tiab] OR epithalon[tiab] OR "Ala-Glu-Asp-Gly"[tiab]): 140; with clinical trial[pt]: 1; with review[pt]: 14.
10 PubMed search for Epitalon, 5 October 2026
Studies
RodentBiogerontology 2003
Lifelong study in female mice of epitalon on biomarkers of ageing, lifespan and spontaneous tumour incidence.
- Design
- Animal study
- Population or model
- female Swiss-derived SHR mice
- Molecule
- Epitalon exact
In vitro or ex vivoBiogerontology 2025
Measured telomere length and telomerase activity in human cell lines exposed to epitalon.
- Design
- In vitro
- Population or model
- human cell lines
- Molecule
- Epitalon exact
PubMed 40908429DOIcorrection: 41240216
In vitro or ex vivoInt J Mol Sci 2025
Overview of in vitro, in vivo and in silico studies of epitalon.
- Design
- Review
- Molecule
- Epitalon exact
In vitro or ex vivoBull Exp Biol Med 2004
Studied proliferative potential and telomerase in human fetal fibroblasts exposed to epithalon.
- Design
- In vitro
- Population or model
- human fetal fibroblasts
- Molecule
- Epithalon exact
Cell culture studies and review
- Cell culture studies of 2004 and 2025 measured telomerase activity, telomere length and proliferative potential in human cells exposed to epitalon. Source sentence
Measured per the PubMed records: proliferative potential and telomerase in human fetal fibroblasts exposed to epithalon; telomere length and telomerase activity in human cell lines exposed to epitalon.
5 Bull Exp Biol Med 20046 Biogerontology 2025 - A 2025 review covers in vitro, in vivo and in silico studies of epitalon. Source sentence
Measured: overview of in vitro, in vivo and in silico studies of epitalon.
3 Int J Mol Sci 2025
Status matrix
EMA
No authorisation found 9 EMA medicines data, 5 October 2026No centrally authorised procedure in the EMA medicines data names epitalon
MHRA
No record found 11 MHRA Products search for epitalon, 5 October 2026No SmPC, PIL or PAR document in MHRA Products matches the exact name epitalon
WADA
Not named 12 WADA Prohibited List 2026The 2026 list does not name this substance; it names substances by example
European Union: EMA records
EU
- No centrally authorised procedure in the EMA medicines data of 5 Oct 2026 names epitalon as an active substance. National authorisations are not in that dataset. Source sentence
EMA medicines JSON report, snapshot 2026-10-05T06:02:03Z: 0 procedures for epitalon; control lookup (semaglutide): 5 procedures.
9 EMA medicines data, 5 October 2026
United Kingdom: MHRA records
UK
- No SmPC, PIL or PAR document in MHRA Products matches the exact name epitalon on 5 Oct 2026. Source sentence
MHRA Products search for the exact name "epitalon" over SmPC, PIL and PAR documents: 0 documents; control lookup (semaglutide): 271 documents.
11 MHRA Products search for epitalon, 5 October 2026
Sport anti-doping list
International
- The WADA 2026 Prohibited List, in force from 1 Jan 2026, does not name this substance. The list names substances by example, so this is not a statement that it is permitted in sport. Source sentence
WADA 2026 Prohibited List text search for Epitalon and its alternative names: no entry; list in force 1 January 2026.
12 WADA Prohibited List 2026
Registry records
- On 5 Oct 2026 ClinicalTrials.gov listed no registered study for the names epitalon or epithalon. Source sentence
query.intr epitalon or epithalon: registered 0.
7 ClinicalTrials.gov search for Epitalon, 5 October 2026
Integrity notes
- PubMed lists an erratum for the 2025 cell line paper on telomere length (PMID 40908429): Biogerontology, 15 Nov 2025, 27(1):1. The paper itself is listed here with that note. Source sentence
PubMed efetch CommentsCorrections for PMID 40908429: ErratumIn, Biogerontology. 2025 Nov 15;27(1):1. doi: 10.1007/s10522-025-10326-8 (PMID 41240216).
6 Biogerontology 2025 - The PubMed records read for the other three studies on this page list no correction, retraction or expression of concern (checked 5 Oct 2026). Source sentence
PubMed efetch CommentsCorrections for PMIDs 14501183, 40141333 and 15455129: none of type ErratumIn, RetractionIn or ExpressionOfConcernIn.
10 PubMed search for Epitalon, 5 October 2026
Other compounds in the Academy
Chemistry and records
Epitalon: sequence, mass, CAS and regulatory record in the research library →
Sources
- 1PubChem CID 219042 accessed 5 Oct 2026
- 2Peptency catalog chemistry record, Epitalon accessed 5 Oct 2026
- 3Int J Mol Sci 2025 accessed 5 Oct 2026
- 4Biogerontology 2003 accessed 5 Oct 2026
- 5Bull Exp Biol Med 2004 accessed 5 Oct 2026
- 6Biogerontology 2025 accessed 5 Oct 2026
- 7ClinicalTrials.gov search for Epitalon, 5 October 2026 accessed 5 Oct 2026
- 8openFDA Drugs@FDA query for epitalon and epithalon, 5 October 2026 accessed 5 Oct 2026
- 9EMA medicines data, 5 October 2026 accessed 5 Oct 2026
- 10PubMed search for Epitalon, 5 October 2026 accessed 5 Oct 2026
- 11MHRA Products search for epitalon, 5 October 2026 accessed 5 Oct 2026
- 12WADA Prohibited List 2026 accessed 5 Oct 2026
About this page
Research-use information. This library summarises published literature and regulator records. It is not guidance for use, not medical advice, and not a statement that any material is suitable for use in people or animals.
Drafted from the verified research library records and passed the Academy schema, cross reference and wording checks. The seven checker rounds used on the earlier compound pages have not been run on this page.. Version 1, edited 16 November 2026, 12 sources.
Cite this page: Peptency Academy. Epitalon: tetrapeptide chemistry, studies and status. Version 1./eu/academy/compounds/epitalon/